SHAREHOLDER ALERT: BLU IQDNX CYDY: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
NEW YORK, NY / ACCESSWIRE / April 27, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.
BELLUS Health Inc. (NASDAQ:BLU)
If you suffered a loss, contact us at:http://www.wongesq.com/pslra-1/bellus-health-inc-investigation-loss-submission-form?prid=15170&wire=1
Lead Plaintiff Deadline: May 17, 2021
Class Period: September 5, 2019 - July 5, 2020
Allegations against BLU include that: while BLU-5937's "high selectivity" contributed to the drug causing little to no taste alteration in chronic cough patients, that high selectivity also contributed to the drug potentially being less efficacious and thus likely not be able to meet the primary endpoint of the Company's Phase 2 trial.
Infinity Q Diversified Alpha Fund Institutional Class (NASDAQ:IQDNX)
If you suffered a loss, contact us at:http://www.wongesq.com/pslra-1/infinity-q-diversified-alpha-fund-loss-submission-form?prid=15170&wire=1
Lead Plaintiff Deadline: April 27, 2021
Class Period: December 21, 2018 - February 22, 2021
Allegations against IQDNX include that: (1) Infinity Q's Chief Investment Officer made adjustments to certain parameters within the third-party pricing model that affected the valuation of the swaps held by the Fund; (2) consequently, Infinity Q would not be able to calculate NAV correctly; (3) as a result, the previously reported NAVs were unreliable; (4) because of the foregoing, the Fund would halt redemptions and liquidate its assets; and (5) as a result, the Prospectuses were materially false and/or misleading and failed to state information required to be stated therein.
CytoDyn Inc. (OTCQB:CYDY)
If you suffered a loss, contact us at:http://www.wongesq.com/pslra-1/cytodyn-inc-loss-submission-form?prid=15170&wire=1
Lead Plaintiff Deadline: May 17, 2021
Class Period: March 27, 2020 - March 9, 2021
Allegations against CYDY include that: CytoDyn securities were actively traded over the counter (OTC) in the United States. While the exact number of Class members is unknown to Plaintiff at this time and can be ascertained only through appropriate discovery, Plaintiff believes that there are hundreds or thousands of members in the proposed Class. Record owners and other members of the Class may be identified from records maintained by CytoDyn or its transfer agent and/or OTC Markets and may be notified of the pendency of this action by mail, using the form of notice similar to that customarily used in securities class actions.
To learn more contact Vincent Wong, Esq. either via email vw@wongesq.com or by telephone at 212.425.1140.
Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com
SOURCE: The Law Offices of Vincent Wong
View source version on accesswire.com:
https://www.accesswire.com/642461/SHAREHOLDER-ALERT-BLU-IQDNX-CYDY-The-Law-Offices-of-Vincent-Wong-Reminds-Investors-of-Important-Class-Action-Deadlines
